Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).

Ribi K, Thürlimann B, Schär C, Dietrich D, Cathomas R, Zürrer-Härdi U, von Briel T, Anchisi S, Bohanes P, Blum V, von Burg P, Mannhart M, Caspar CB, von Moos R, Mark M

Open source

DOI
10.1186/s12885-021-07903-8
Published
2021 Feb 19
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-021-07903-8,
  title = {Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).},
  author = {Ribi K and Thürlimann B and Schär C and Dietrich D and Cathomas R and Zürrer-Härdi U and von Briel T and Anchisi S and Bohanes P and Blum V and von Burg P and Mannhart M and Caspar CB and von Moos R and Mark M},
  year = {2021},
  journal = {BMC cancer},
  doi = {10.1186/s12885-021-07903-8},
  url = {https://doi.org/10.1186/s12885-021-07903-8}
}

RIS

TY  - JOUR
TI  - Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).
AU  - Ribi K
AU  - Thürlimann B
AU  - Schär C
AU  - Dietrich D
AU  - Cathomas R
AU  - Zürrer-Härdi U
AU  - von Briel T
AU  - Anchisi S
AU  - Bohanes P
AU  - Blum V
AU  - von Burg P
AU  - Mannhart M
AU  - Caspar CB
AU  - von Moos R
AU  - Mark M
PY  - 2021
JO  - BMC cancer
DO  - 10.1186/s12885-021-07903-8
UR  - https://doi.org/10.1186/s12885-021-07903-8
ER  - 

APA

K, R., B, T., C, S., D, D., R, C., U, Z., T, V. B., S, A., P, B., V, B., P, V. B., M, M., CB, C., R, V. M., & M, M. (2021). Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).. BMC cancer. https://doi.org/10.1186/s12885-021-07903-8

Source records